Victory Capital Management Inc Atossa Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $95.7 Billion
  • Q4 2024

A detailed history of Victory Capital Management Inc transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 15,555 shares of ATOS stock, worth $11,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,555
Previous 15,956 2.51%
Holding current value
$11,977
Previous $24,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$0.94 - $1.62 $376 - $649
-401 Reduced 2.51%
15,555 $14,000
Q3 2024

Nov 05, 2024
SELL
$1.09 - $1.52 $265 - $370
-244 Reduced 1.51%
15,956 $24,000
Q2 2024

Aug 05, 2024
BUY
$1.03 - $2.1 $16,686 - $34,020
16,200 New
16,200 $19,000
Q3 2023

Nov 06, 2023
SELL
$0.74 - $1.35 $31 - $56
-42 Reduced 0.3%
13,823 $10,000
Q2 2023

Jul 27, 2023
SELL
$0.6 - $1.28 $192 - $410
-321 Reduced 2.26%
13,865 $17,000
Q1 2023

May 02, 2023
SELL
$0.59 - $0.91 $109 - $168
-185 Reduced 1.29%
14,186 $10,000
Q4 2022

Feb 09, 2023
SELL
$0.5 - $1.01 $2 - $5
-5 Reduced 0.03%
14,371 $7,000
Q3 2022

Nov 02, 2022
SELL
$0.82 - $1.14 $1,047 - $1,456
-1,278 Reduced 8.16%
14,376 $12,000
Q2 2022

Aug 01, 2022
SELL
$0.85 - $1.28 $90 - $136
-107 Reduced 0.68%
15,654 $17,000
Q1 2022

May 04, 2022
SELL
$1.11 - $1.74 $1,724 - $2,703
-1,554 Reduced 8.97%
15,761 $16,000
Q4 2021

Feb 07, 2022
SELL
$1.6 - $3.27 $862 - $1,762
-539 Reduced 3.02%
17,315 $28,000
Q3 2021

Nov 02, 2021
SELL
$2.89 - $6.4 $1,774 - $3,929
-614 Reduced 3.32%
17,854 $58,000
Q2 2021

Aug 03, 2021
BUY
$1.52 - $8.62 $11,279 - $63,969
7,421 Added 67.18%
18,468 $117,000
Q1 2021

May 04, 2021
BUY
$0.92 - $4.33 $10,163 - $47,833
11,047 New
11,047 $23,000
Q2 2020

Aug 07, 2020
SELL
$1.04 - $4.05 $1,612 - $6,277
-1,550 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$0.79 - $1.62 $27 - $56
-35 Reduced 2.21%
1,550 $2,000
Q4 2019

Feb 04, 2020
SELL
$1.25 - $1.87 $71 - $106
-57 Reduced 3.47%
1,585 $2,000
Q3 2019

Nov 12, 2019
BUY
$1.96 - $2.52 $3,218 - $4,137
1,642 New
1,642 $3,000

Others Institutions Holding ATOS

# of Institutions
92
Shares Held
27.1M
Call Options Held
466K
Put Options Held
91.8K
View Full List

About ATOSSA THERAPEUTICS, INC.

ATOS Quotes by TradingView
  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $97.5M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email